Eduard Serra

Ruijin Hospital — China

Medicine · Health Sciences

30h-index5.8kcitations155works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurofibromatosis and Schwannoma Cases(99), Neuroblastoma Research and Treatments(51), Sarcoma Diagnosis and Treatment(35), Nerve injury and regeneration(19), Chromatin Remodeling and Cancer(14)

Publications154 total

The benefits of a rapid diagnostic primary care circuit for interstitial lung disease
npj Primary Care Respiratory Medicine·2025Open Access
<i>NF2</i> lacking exon 11 induced by antisense gene therapy is able to partially recover merlin deficiency on <i>NF2</i> -SWN iPSC-derived spheroid model
2025
P1.04.47 Breathomics Meets Deep Learning: A Novel Approach for Early Detection of Lung Cancer
Journal of Thoracic Oncology·2025
Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors
Nature Communications·2025Open Access
iPSC-derived <i>NF1</i> - <i>CDKN2A</i> -PRC2 deficient neural crest mimics MPNST glial-to-neuro-mesenchymal transition and uncover new therapeutic opportunities
2025Open Access
The Benefits of a Rapid Diagnostic Primary Care Circuit for Interstitial Lung Disease
2025Open Access
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines
Cancer Cell International·2025· 1 citedOpen Access
New Models for MPNST: Establishment and Comprehensive Characterization of Two Tumor Cell Lines
2025Open Access
iPSC-based merlin-deficient Schwann cell-like spheroids as an in vitro system for studying NF2 pathogenesis
Genes & Diseases·2025· 1 citedOpen Access
A new approach to quantify information in real-life, complex neuroscience processes. Comment on “Kinematic coding: Measuring information in naturalistic behavior” by Becchio, Pullar, Scaliti and Panzeri
Physics of Life Reviews·2025· 1 cited
Immortalization and Characterization of Schwann Cell Lines Derived from NF1 Associated Cutaneous Neurofibromas
2025· 1 citedOpen Access
Supplementary Figure S6 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
Data from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025· 2 citedOpen Access
Supplementary Data S1 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
Supplementary Figure S7 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
Supplementary Figure S8 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
Supplementary Figure S3 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
Supplementary Table S4 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
Supplementary Figure S10 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
Supplementary Figure S11 from Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
2025Open Access
page 1 of 8Next →

Frequent Co-authors

Conxi Lázaro(34), Ignacio Blanco(20), Bernat Gel(14), Elisabeth Castellanos(12), Juana Fernández‐Rodríguez(9), Ernest Terribas(9), Inma Rosas(9), Gabriel Capellá(8), Meritxell Carrió(7), Xavier Estivill(6), Nancy Ratner(6), Hildegard Kehrer‐Sawatzki(5), Elisabet Ars(5), Eva Pros(5), Helena Mazuelas(5), Eric Legius(4), Anat Stemmer‐Rachamimov(4), Marco Giovannini(4), Lu Q. Le(4), H. Kruyer(4)